The effects of the recently identified FLK-Z/FLT-3 ligand (FL) on the growth of purified human fetal liver progenitors were investigated under serum-deprived culture conditions. FL alone was found t o stimulate modest proliferation in shortterm cultures of CD34++ CD38' lineage (Lin)-light-density fetal liver (LDFL) cells and the more primitive CD34++ CD38-Lin-LDFL cells. However, the low levels of growth induced by FL were insufficient for colony formation in clonal cultures. Synergism between FL and either granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3) or KIT ligand (KL) was observed in promoting the growth of high-proliferative potential (HPP) colony-forming cells (CFC) andlor low-proliferative potential (LPPI-CFC in cultures of CD34++ CD38' Lin-and CD34++ CD38-Lin-LDFLcells. FL, done or in combination with other cytokines, was not found t o affect the growth of CD34+ Lin-LDFL cells, the most mature subpopulation of fetal liver progenitors investigated. The growth of the most primitive subset of progeni-
T HE FLK-2/FLT-3 RECElTOR tyrosine kinase was
identified based on the homology of this protein with other tyrosine kinases and was found to belong to the type I11 receptor tyrosine kinase family which includes KIT (CD1 17), FMS (CD1 15), and the PDGF-re~ept0r.l~ The expression ofJlk-Z@t-3 mRNA was observed in early murine hematopoietic progenitors isolated from fetal liver, adult thymus, and adult bone Likewise, human Jlk-2@t-3 mRNA was also found to be expressed in thymus, spleen, and bone marrow progenitors expressing CD34.3*4
As predicted by the pattern of fik-2Ijlt-3 expression and the homology of this receptor to other hematopoietic growthfactor receptors, the recently identified FLK-2mT-3 ligand (FL) was shown to be active in promoting the growth of murine and human hematopoietic progenitor^?.^ FL alone did not stimulate a strong proliferative response from purified populations of murine hematopoietic progenitor^.^.^ However, FL was shown to synergize with other growth factors such as KIT-ligand (KL), interleukin-3 (IL-3), and IL-6 in promoting the proliferation and/or colony formation by purified progenitom6 FL was also found to synergize with IL-3 and granulocyte-macrophage colony-stimulating factor (GM-CSF) in stimulating colony formation by human hematopoietic progenitors isolated from fetal liver, bone marrow, and cord
In contrast to the stimulatory effects of FL on myelopoiesis, no effect of F% was observed on either murine or human erythrop~iesis.~,~ Hematopoietic progenitors have been found to express CD34, while being heterogeneous for the expression of other cell surface antigens. The most primitive progenitors/stem cells express the highest levels of CD34.'"' Conversely, the level of CD38 expression on hematopoietic progenitors increases with differentiation.".12 Thus, stem cells are believed to be found among CD34++ CD38-cells from which they differentiate into committed progenitors expressing CD38 (CD34++ CD38') and subsequently downregulating CD34 expression (CD34+ CD38+). We have recently reported that Blood, Vol 85, No 4 (February 15). 1995: pp [963] [964] [965] [966] [967] [968] [969] [970] [971] [972] tors studied, CD34++ CD38-Lin-LDFL cells, required the interactions of at least two cytokines, because only very low levels of growth were observed in response to either FL, GM-CSF, IL-3 or KL alone. However, the results of delayed cytokine-addition experiments suggested that individually these cytokines did promote the survival of this early population of progenitors. Although two-factor combinations of FL, KL, and GM-CSF were observed to promote the growth of early progenitors in a synergistic manner, neither of these factors was found to make fetal liver progenitors more responsive to suboptimal concentrations of a second cytokine. Only myeloid cells were recovered from liquid cultures of CD34++ CD38-Lin-LDFL cells grown in the presence of combinations of FL, KL, and GM-CSF. These results indicate that FL is part of a network of growth factors that regulate the growth and survival of early hematopoietic progenitors. 0 1995 by The American Society of Hematology.
this scheme of hematopoietic differentiation appears to be valid for human fetal liver progenitor^.'^ In this study, we have examined the role of FL in regulating the growth of subpopulations of fetal liver progenitors isolated based on the expression of CD34 and CD38. The results demonstrate that FL acts on immature hematopoietic progenitors and requires the presence of other cytokines such as KL, GM-CSF, or L -3 for its maximal effect.
MATERIALS AND METHODS

Cytokines.
Recombinant human (rh) KL and rhIL-3 were purchased from R & D Systems, Inc (Minneapolis, MN) and rhGM-CSF was provided by Schering-Plough Corp (Kenilworth, NJ). Unless otherwise indicated KL, GM-CSF, and IL-3 were used at 20 ng/ m L , concentrations determined to give rise to a maximal number of colonies in colony-forming unit culture (CFU-C) assays. Recombinant murine (rm) FL and rhFL were produced at our institute. A mouse FL fragment, encoding amino acid residues 28 to 162, was isolated by polymerase chain reaction (PCR) using T118 cDNA clone6 as a template. The 5' primer that was used, inserted the sequence CATATG directly upstream of residue 28 encoding a Nde I restriction site and a methionine start codon. The 3' PCR primer introduced a TAAGGATCC sequence immediately downstream of
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Gly162 encoding a stop codon followed by a BamHl site (Biolabs, Beverly, MA). The fragment was isolated and inserted into Nde I-and BumHI-digested pET3a (Novagen, Madison, WI). Freshly transformed Escherichia coli carrying murine FL pET3a were grown in freshly prepared LYM-1 medium (Difco, Mauston, WI) and induced with isopropol P-D-thiogalactopyranoside (IPTG; Sigma Chemical CO, St Louis, MO). After 4 hours of induction, the bacteria were harvested and the inclusion bodies isolated. The inclusion bodies were washed once in 50 mmoVL Tris[hydroxymethyl]-aminomethane hydrochloride (Tris) buffer pH 8.5 (Sigma Chemical CO) containing 1% Triton-X 100 (Sigma Chemical CO) and then in Tris buffer alone. The washed inclusion bodies were solubilized in Tris buffer containing 6 mom guanidine HCI (Sigma Chemical CO) and 10 mmoVL dithiothreitol (Sigma Chemical CO) at pH 8.5. The solubilized inclusion bodies were refolded by dilution (100-fold) in 50 mmol/L Tris HCI pH 8.5 containing 2.5 mmolR. reduced glutathione (Sigma Chemical CO), 0.5 mmom oxidized glutathione (Sigma Chemical CO) and 0.15 mom NaCl. The protein was allowed to renature for 24 hours, whereafter the protein was concentrated and stored at 4°C or diafiltered into 50 mmol/L N- [2hydroxymethyl] piperazine-N'-[2ethane sulfonic acid] (HEPES) buffer pH 7.5 containing 0.15 mol/L NaCl. The renatured protein was purified either by chromatography on a Reverse Phase column (Poros R2; Perseptive Biosystems, Cambridge, MA), using a gradient of acetonitrile containing 0.1% trifluroacetic acid (TFA; Pierce, Rockford, IL) to elute the bound proteins or by sequential chromatography on an anion exchange column (Poros Q 4.6 mm X 10 mm; Perseptive Biosystems) at pH 8.5 and on a cation exchange column (Poros S 4.6 X 10 mm; Perseptive Biosystems) at pH 4.0. The protein peaks were assayed for activity using Baf 3 cells expressing murine FLK-2/ FLT-3 (mBaflt cells)! Active fractions were pooled, dried under vacuum, and stored at 4°C. The protein was resuspended in phosphate-buffered saline (PBS) for determining activity and pyrogen levels. The pyrogen levels were less than 10 EUlmL as determined by the Limulus Amebocyte Lysate method as described by the manufacturer Whittaker Bioproducts, Inc (Walkersville, MD). The protein was quantitated by scanning a Commassie stained gel using a Molecular Dynamics scanner (Sunnyvale, CA). Unless otherwise stated, rmFL was used in these studies at a concentration of 25 Baflt units/ m L , the minimum concentration found to result in maximal colony formation by CD34++ CD38-Lin-light-density fetal liver (LDFL) cells in the presence of 20 ng/mL GM-CSF.
rhFL was expressed in NSO cells using the glutamine synthetase (GS) expression system as described.14 The BumHI fragment of the human FL S86 cDNA clone6 was inserted into the Bcl I site of the GS vector pEEl2 (Celltech Limited, Berkshire, United Kingdom). The resulting plasmid was linerized with HindIII, transfected into NSO cells, and several clones stably expressing soluble rhFL were isolated under subsequent selection in glutamine-free media as recommended by the supplier. One such clone was cultured in selection medium containing fetal bovine serum (FBS) to a density of about 5 x l@ cells/mL. The cells were then washed four times in PBS to remove FBS and recultured in an equivalent volume of culture medium comprised of Dulbecco's modified Eagle's medium and 0.5% penicillidstreptomycin solution (JRH Biosciences, Lenexa, KS). After 1 week, cells and debris from a 400 mL culture were removed by centrifugation and filtration (0.2 pm), and the supernatant was loaded onto an anion-exchange Q Sepharose column (16/100; Pharmacia) equilibrated in 50 mmovL Tris-HCI pH 8.0. The column was eluted with a gradient of NaCl(0 to 300 mmoVL) in the same buffer and biologically active fractions (determined in proliferation assays using Baf3 cells expressing human FLK-2/FLT-36) were pooled and purified by reverse phase chromatography (Poros R2/M, 4.6/100 mm; Perseptive Biosystems) in 0.1% TFA with elution from 25% to 50% acetonitrile 0.1% TFA over 20 minutes at 2 W m i n . Biologically active fractions (eluting at approximately 13 minutes) were pooled and purified by size exclusion chromatography (bio Si1 Sec-250, 600 X 7.5 mm: BioRad, Oakland, CA) in sodium phosphate pH 6.7, 150 mmol/L NaCI, 0.01% Tween 20 (Sigma Chemical CO) at 1 mWminute. Fetal livers were prepared for fluorescence-activated cell sorting (FACS) by density centrifugation and immunomagnetic bead depletion (Dynal Inc, Great Neck, NY) of erythroid cells as previously described." These GPA-LDFL cells were then stained with PElabeled MoAbs against the Lin markers CD3, CD8, CDIO, CD14, CD1 6, CD19, CD20, and CD56 and subjected to a second round of immunomagnetic bead depletion. The Lin-LDFL cells were then stained with CD34-biotin followed by streptavidin-APC and CD38-FITC. FACS was accomplished by setting an electronic gate on cells with a low side light-scatter and a moderate forward light-scatter." These cells were subdivided into three populations based on negative staining for Lin markers and according to their level of CD34 and CD38 expression (Fig 1) . Three subpopulations of fetal liver progenitors, CD34+ Lin-, CD34++ CD38+ Lin-and CD34+> CD38-Lin LDFL-cells, were isolated by FACS using either a FACStar Plus or Vantage (Becton Dickinson) flow cytometer.
Serum-deprived culture medium. Serum-deprived culture medium consisted of Iscove's modified Dulbecco's medium (IMDM; Sigma Chemical CO) supplemented with 7.5 X IO-' M a-thioglycerol (Sigma Chemical CO), 50 pg/mL gentamicin (GIBCO BRL, Grand Island, NY), 2% fraction-V ethanol-extracted bovine serum albumin (BSA: Boehringer Mannheim Biochemicals, Indianapolis, IN), 200 pg/mL human iron-saturated transferrin (Boehringer Mannheim Biochemicals), 10 HglmL recombinant human insulin (Boehringer Mannheim Biochemicals), and 40 pg proteinlmL human low density lipoprotein (Sigma Chemical CO).'~." This serum-deprived culture medium was used in all cultures of fetal liver cells except for the assays of primary and secondary CFU-C as part of the delta (A)-assay for which the culture medium consisted of IMDM supplemented with 7.5 x IO-' mol/L a-thioglycerol, 50 pg/mL gentamicin and 20% FBS (Sigma Chemical CO).
CFU-C ausay.s. CFU-C were enumerated in double-layered clonal cultures as previously described.'? CD34++ CD38' Lin-LDFL cells, CD34++ CD38-Lin" LDFL cells and cells generated in A-cultures were assayed for CFU-C in 60 X 15 mm tissue culture Reanalysis of the fetal liver subpopulations sorted using the electronic gates shown in (Al. dishes (Becton Dickinson) in a total volume of 3 mL. Triplicate cultures were scored for the presence of high-proliferative potential (HPP) colony-forming cells (CFC) and low-proliferative potential (LPP)-CFC after 3 weeks of growth." HPP-CFC were defined by colonies with a diameter greater than 0.5 mm," whereas LPP-CFC were defined by colonies smaller than HPP-CFC but greater than SO cellslcolony. Due to the reduced growth potential of CD34+ Lin-LDFL cells, these cells were cultured in 35 X 15 mm tissue culture dishes (Becton Dickinson) in a total volume of 1.5 mL. Colonies in cultures of CD34' Lin-LDFL cells were counted after 2 weeks of growth from triplicate cultures. Two classes of progenitors were scored in these cultures: CFU-C that consisted of colonies greater than SO cellskolony and clusters consisting of IO to 50 cellslcolony.
In experiments in which the effects of delaying the addition of cytokines to cultures of CD34" CD38-Lin-LDFL cells were determined, cultures were initiated with a single cytokine, either IL-3. GM-CSF, FL, or KL, which was added to the bottom layer of the double-layered cultures. Cytokines were subsequently added at 0 to 96 hours after the initiation of culture resulting in a final growth stimulus of GM-CSF + KL + FL or GM-CSF + IL-3 + KL + FL.
A-assay.^. Details on the use of the A-assay for measuring the expansion of progenitors during 7 days of liquid culture have been previously described.lN In this study, the liquid cultures were initiated with 900 CD34" CD38-Lin-LDFL cells in I mL of serumdeprived medium supplemented with growth factors as indicated. Primary CFU-C were determined from triplicate cultures of 300 CD34" CD38-Lin-LDFL cellslculture. Secondary CFU-C were assayed from A-cultured cells diluted onefold to 540-fold depending on the degree of cellular expansion observed with the different cytokine combinations. Primary and secondary CFU-C were measured in cultures containing serum and KL + GM-CSF.
Proliferation nssa~a. The proliferation of subpopulations of fetal liver progenitors in response to cytokines was determined by measuring the incorporation of 'H-thymidine (Amersham, Arlington Heights, IL) during a 7-hour pulse with I .O pCi on the first or fourth day of culture. Quadruplicate cultures were established with 1,250 or 500 sorted fetal liver cells in 96-well flat-bottom tissue-culture plates (Becton Dickinson) in a volume of 1 0 0 pL serum-deprived medium containing the indicated concentrations of cytokines.
Phenotypic and morphologic analvsis of cultured fetal liver pro-'qenitors. The morphology of fetal liver cells generated in liquid cultures was determined using standard Wright-Giemsa stained cytospin preparations. The cell surface phenotype of cultured fetal liver cells was determined by three-color cytofluorimetry using a FACScan (Becton Dickinson). Cells were preincubated for IO minutes and stained with labeled MoAbs for 30 minutes in PBS supplemented with l mmolL EDTA, 50 pglmL gentamicin, O S % human gamma-globulins (Sigma Chemical CO), and 2% normal mouse serum. After staining, the cells were washed and resuspended in PBS containing 0.5% BSA, 0.05% NaNl and 1 pglmL propidium iodide (Sigma Chemical CO). FACScan analysis was done gating on live, propidium-iodide negative, cells.
Data presentation and sraristicul unalvsis. The data from multiple experiments were pooled and are presented as the mean of results from individual experiments + I standard error of the mean (SE).
Data from a single representative experiment are presented as the mean of replicate measurements 5 SE. Statistical significance was determined on individual experiments (single tissues) using the twotailed paired Student's t-test. Differences in the data were considered significant when P S .OS in the majority of experiments. The range of P values are given in the text for results from multiple experiments.
RESULTS
FL enhances colony formation by CD34" CD38-and CD34" CD38'
LDFL-cells. The effects of the cytokines FL, KL, GM-CSF, and IL-3 on the growth of CD34" CD38-Lin-, CD34" CD38' Lin-, and CD34' Lin-LDFLcells were studied. In clonogenic cultures, FL alone did not promote the growth of any of the three sorted populations (Fig 2) . It Thus, these results demonstrate that FL, when combined with growth factors such as IL-3, GM-CSF, or KL, is capable of promoting the growth of primitive progenitors found among the CD34" Lin-fraction of fetal liver cells but FL does not effect the proliferation of the more mature CD34' Lin-fraction of fetal liver progenitors. KL had a remarkable positive effect on the growth of all three fetal liver progenitor subpopulations evaluated. KL alone was capable of stimulating colony growth in cultures of all three progenitor subpopulations (Fig 2) . Colonies in KL-stimulated cultures were, however, always of modest size. Combining KL with GM-CSF or 1L-3 increased both the size and number of colonies. The combinations of KL + IL-3 or KL + GM-CSF thus resulted in a significant ( P was observed to be even greater in the presence of FBS, thus demonstrating that fetal liver CFU-C were highly enriched by our purification protocol.
FL promotes the growth of CD34++ CD38-Lin-LDFL cells in A-cultures. The ability of FL to affect the growth of CD34++ CD38-Lin-LDFL cells was further characterized using the A-assay (Fig 3) . In contrast to the lack of colony formation observed in clonal cultures stimulated with FL alone, in three experiments FL was able to promote the survivaVgrowth of at least a fraction of CD34++ CD38-Lin-LDFL cells when compared with unstimulated A-cultures ( P = .020 to .l20 for HPP-CFC and P = .002 to .045 for LPP-CFC). However, as with GM-CSF-stimulated Acultures, the number of CFU-C recovered from FL-stimulated A-cultures was less than the number of CFU-C used to initiate the A-cultures. In contrast, KL alone was able to promote a mean 2.0-and 5.9-fold increase in HPP-CFC ( P 5 .069 v medium) and LPP-CFC ( P 5 For personal use only. on October 30, 2017. by guest www.bloodjournal.org From CSF, because less than 1% of the recovered cells expressed CD3, CD8, CD10, CD19, CD20, and/or CD56 (data not shown). The expression of cell surface markers by the cultured fetal liver progenitors shows that the bulk of the recovered cells are myeloid (Table l) , with no dramatic differences existing between the cultures stimulated with or without FL. After 3 weeks of culture the majority of the cells were monocytes as indicated by the expression of CD18, CD14, CD1 IC, CD1 Ib, and CD4.
Wright-Giemsa stained cells recovered after 1 week of Aculture were identified as a mixture of undifferentiated blast cells and myeloid cells of various stages of maturation. The morphology of cells recovered after 3 weeks of growth from KL + GM-CSF-and FL + KL + GM-CSF-stimulated cultures confirmed the presence of a high number of monocytes (59% and 67%, respectively) and basophiVmast cells (33% and 27%, respectively) with only a few neutrophils (4.5% and 5.5%, respectively) being observed. Additionally, cells harvested from A-cultures stimulated with only FL were identified as a mixture of monocytes, immature myeloid cells, and a predominance of dead cells.
FL promotes the proliferation of early hematopoietic progenitors. The results from the CFU-C assays (Fig 2) and the A-assays (Fig 3) demonstrated that KL alone is capable of stimulating the growth of a broad spectrum of progenitors. In contrast, the ability of FL to stimulate the proliferation, and not just the survival, of progenitors could not be concluded from these assays. The ability of FL to promote the growth of fetal liver progenitors was, therefore, ascertained in assays measuring proliferation using a pulse of 'H-thymidine on the fourth day of culture (Fig 4A) . FL did not affect the proliferation of CD34' Lin-LDFL cells, but FL did stimulate the proliferation of CD34+' CD38' Lin-and CD34'+ CD38-Lin-LDFL-cells ( P = .001 and .002, respectively). The proliferation of CD34" CD38' Lin-and CD34" CD38-Lin-LDFL-cells in response to FL + KL was greater than that observed with KL alone ( P = .066 and .002, respectively). The lowest levels of proliferation were measured in cultures of CD34++ CD38-Lin" LDFL cells, and it was in these cultures that the synergism between FL and KL was most significant. Significant proliferation of CD34" CD38-Lin-LDFL cells after only 24 hours of culture was seen in response to KL ( P = ,006 v medium) but not in response to either GM-CSF, IL-3, or FL (Fig 4B) . Strong synergism between KL and GM-CSF or IL-3 was also apparent ( P 5 ,002 v KL and GM-CSF or IL-3, respectively). Further increases in proliferation were observed with the addition of FL to KL + GM-CSF ( P = ,002) and to KL + IL-3 ( P = .007). FL, KL, or GM-CSF in the presence of a second cytokine demonstrate synergism but no cytokine sensitization. KL and FL were tested at various concentrations for their effect on the proliferation of CD34+' CD38' Lin-LDFL cells ( Fig  4C) . KL alone or together with GM-CSF stimulated halfmaximal proliferation at 5.4 and 4.5 nglmL, respectively. Growth in response to optimal concentrations of KL was always greater than that measured with optimal concentrations of l % . Half-maximal proliferation with FL alone was found at a concentration of 27 Baflt units/mL. Similarly, in the presence of GM-CSF half-maximal proliferation with FL was observed at 20 Baflt units/mL. Because the specific activity of rmFL has been estimated at I X IO' Baflt units/ mg (data not shown), the data indicate that high concentrations of FL are required for the maximum stimulation of growth of hematopoietic progenitors, in agreement with recently published result^.^ In contrast to the synergism observed between FL and GM-CSF on CD34"' CD38' Lin LDFL cells, no such synergism in promoting the proliferation of CD34' Lin-LDFL cells was observed over a concentration range of up to 2.5 X lo3 BaRt units/mL FL and 100 pg/mL GM-CSF (data not shown). These data further confirm the observation that FL is only active on early progenitors.
As previously reported, the activities of rhFL and rmFL are similar on both Baflt cells constructed with either murine FLK-2/FLT-3 or human FLK-2/FLT-3.' Furthermore, both rhFL and rmFL had comparable activity on the proliferation of CD34" CD38' Lin-LDFL cells (data not shown). Thus, suggesting that murine FL has the same activity as human FL in stimulating the growth of human progenitors.
The synergism between FL or KL and GM-CSF was further investigated over a range of GM-CSF concentrations (a representative experiment is shown in Fig 4D) . As predicted from clonal assays (Fig 2) , the greatest proliferation was observed in the presence of >20 pg/mL GM-CSF + 20 ng/ mL KL, which was 3.0-to 5.6-fold higher than in cultures stimulated with >20 pg/mL GM-CSF + 25 Baflt units/mL FL (n = 2). The ability of an optimal concentration of KL or FL to sensitize progenitors to suboptimal levels of GM-CSF was ascertained by comparing the concentration of GM-CSF, alone or combined with KL or FL, required for halfmaximal proliferation ( Table 2 ). The data demonstrate that although a greater number of progenitors are recruited to grow in response to the combinations of FL + GM-CSF and KL + GM-CSF than to GM-CSF alone, the dose-response of progenitors to GM-CSF is similar whether in the presence or the absence of FL or KL.
Individually the cytokines FL, KL, GM-CSF and IL-3 can promote the survival of primitive progenitors. The data presented thus far demonstrate that combinations of at least two cytokines are required for the high-proliferative potential of the most primitive, CD34" CD38-Lin-, population of fetal liver cells to be realized. Individually, however, the cytokines FL, KL, GM-CSF and IL-3 are capable of promoting the modest growth and/or survival of CD34" CD38~-Lin ~ LDFL cells. The effects of single cytokines on primitive progenitors were further investigated by initiating clonal cultures of CD34" CD38-Lin-LDFL cells in the presence of either FL, KL, GM-CSF, or IL-3 followed by a deiayedsecondary addition of multiple cytokines to promote the maximal growth of CFU-C (Fig 5) . Significant loss of CFU-C viability was observed in cultures of serum-deprived medium after 12 hours. The presence of any of the four tested cytokines during the first four days of culture promoted the survival of CFU-C relative to unstimulated cultures. IL-3 and KL were better than GM-CSF and FL at maintaining CFU-C viability, with a significant loss of input CFU-C occurring after at least 4 days of culture. Furthermore, the data in Fig 5 are presented as the total CFU-Ckulture because both HPP-CFC and LPP-CFC responded in a similar fashion to the delayed addition of cytokines (data not shown). Thus, these delayed-addition experiments did not suggest any differences between the HPP-CFC and LPP-CFC subpopulations of CD34" CD38-Lin-LDFL cells in their response to cytokine deprivation.
DISCUSSION
The expression ofjk-2lflt-3 mRNA has been detected in populations of early murine hematopoietic progenitors and human CD34', but not CD34-, bone marrow cells. Antisense oligonucleotides directed againstJk-2/flt-3 mRNA were also shown to inhibit the growth of human progenitors in longterm bone marrow cultures. It was thus hypothesized that FL, once identified, would constitute a hematopoietic growth factor with activity on early progenitors/stem cells.',' The data in this study support this hypothesis. FL did not affect the growth of mature CD34' Lin progenitors, but FL was found to affect the early stages of fetal liver myelopoiesis by acting on CD34" CD38-Lin-and CD34" CD38' Lin LDFL cells. FL was shown to synergize with either GM- CSF, IL-3, or KL in promoting the growth of CFU-C, the expansion of progenitors in A-cultures, and in stimulating the growth of progenitors in short-term proliferation assays. The most prominent synergistic effects of FL were observed in cultures of primitive CD34++ CD38-Lin-LDFL cells. We have recently reported that these CD34" CD38-Lin-LDFL cells, which share the phenotypic profile associated with stem cells, are enriched in HPP-CFC." Nevertheless, the culture conditions used in this study supported only the myeloid differentiation of these multipotent progenitors.
Studies on murine progenitors have shown that combinations of cytokines are required for the growth of the most primitive progenitodstem cells and that coinciding with the maturation of these progenitors is the loss of the requirement of multiple cytokines for g r o~t h . '~, ' " '~ Likewise, the growth of early human progenitors, including HPP-CFC, has also been shown to be dependent on multiple cytokines.''-'' The synergisms observed with combinations of IL-3, GM-CSF, FL, and KL on CD34++ CD38-Lin-LDFL cells do suggest similar regulatoq mechanisms for early human fetal liver progenitors as for early mouse and adult human bone-marrow progenitors. With the maturation of progenitors from CD34" CD38-Lin-to CD34++ CD38+ Lin-LDFL cells, we observed a loss in progenitor proliferative capacity.'' Herein we demonstrate that with the maturation of fetal liver progenitors to CD34" CD38'
Lin-LDFL cells, there is also an increased responsiveness to single cytokines and a consequential reduction in the synergism between cytokines. Although the ability of progenitors to grow in response to a single cytokine increases with maturation, the data presented suggest that synergistic interactions of cytokines appear important in maximizing hematopoiesis throughout the different stages of progenitor maturation.
FL alone was capable of stimulating modest proliferation by CD34" CD38' Lin" and CD34'+ CD38-Lin-LDFL progenitors. The proliferation stimulated by FL was, how- ever, insufficient to result in any appreciable colony formation in clonal cultures. These findings differ from our initial observations that colony formation, in serum containing cultures, increased slightly in response to F L . 6 These results were likely due to the interaction of FL with serum-derived cytokines. The serum-deprived culture medium used in this study did not contain any colony-stimulating activity. Thus, we could demonstrate that individually GM-CSF, IL-3, and KL do stimulate some colony formation by CD34++ CD38-Lin-LDFL cells whereas FL does not.
In contrast to FL, KL was able to stimulate the growth of myeloid progenitors throughout their maturation. The growth of the most mature subpopulation of fetal liver progenitors, CD34+ Lin-LDFL cells, was unaffected by FL and was unremarkably stimulated by IL-3 or GM-CSF. KL had notable colony-stimulating activity on CD34+ Lin-LDFL cells by itself and synergism between KL and either GM-CSF or IL-3 was also observed. These results are in agreement with the previous observation by Sonoda et alZ4 that IL-3 and GM-CSF do not promote the final stages of progenitor growth unless combined with other cytokines such as G-CSF or EPO. The effects of L -3 and GM-CSF, like those of KL, were observed on all three subpopulations of progenitors although, individually, IL-3 and GM-CSF exerted their greatest effects on the intermediate subpopulation of CD34++ CD38+ Lin-LDFL progenitors. Collectively, these results demonstrate the functional diversity of fetal liver progenitors, which can be isolated on the basis of a continuum of CD34 and CD38 expression.
To examine the mechanisms by which synergism between cytokines occurs, the dose responses of progenitors to individual cytokines were studied, both in the presence and absence of a second cytokine. Dose titrations of FL and KL, alone or in the presence of a single concentration of GM-CSF, demonstrated that FL and KL were active over a similar concentration range whether in the presence or absence of GM-CSF. Likewise, the dose responses of CD34" CD38+ Lin-LDFL cells to GM-CSF in the presence or absence of single concentrations of either FL or KL were also similar. Thus, combinations of cytokines did synergize in recruiting a greater number of progenitors to grow, but there was no apparent sensitization of progenitors to suboptimal concentrations of one cytokine due to the presence of a second cytokine. These results are somewhat in contrast to the conclusions of Lowry et aiz5 who observed that optimal concentrations of KL could stimulate colony formation by murine HPP-CFC in the presence of suboptimal concentrations of a cytokine cocktail, which alone did not stimulate HPP-CFC. These discordant observations may be due to the differences in the sensitivities of colony assays and proliferation assays used to measure the growth of progenitors.
The enhanced survival of CD34++ CD38-Lin-LDFL cells in response to individual cytokines was demonstrated in clonal cultures in which the addition of multiple cytokines, required for colony formation, was delayed. The survival/ growth of HPP-CFC and LPP-CFC was observed in the presence of either GM-CSF, IL-3, FL, or KL. IL-3 and KL appeared, however, slightly more effective than GM-CSF and FL in preventing the death of early progenitors. A similar effect of KL on the survival of murine HPP-CFC has been demonstrated, although in the presence of serum.26 Brandt et alZ7 have also reported the survival of human CD34' HLA-DR+ bone marrow cells in the presence of IL-3 and the survival of CD34+ HLA-DR-bone marrow cells in the presence of KL under serum free conditions. The proliferation experiments done in this study (Fig 4B) showed that single cytokines could induce only very limited growth of CD34++ CD38-Lin-LDFL cells and thus the survival of early progenitors may not necessarily involve their proliferation as well. We also did not observe that early progenitors respond to cytokine deprivation with changes in proliferative capacity, because similar ratios of HPP-CFC and LPP-CFC were observed whether these progenitors were stimulated with a combination of cytokines at the onset of culture or whether they were preincubated in the presence of a single growth factor. Thus, HPP-CFC did not differentiate into LPP-CFC when stimulated by either GM-CSF, IL-3, FL, or KL before being stimulated by all four cytokines. Further analyses are needed to determine if other cytokines can induce the rapid differentiation or enhance the proliferative capacity of stem cells in vitro.
A number of studies have suggested that the mechanisms of stem cell maintenance in vivo do not depend on KL, although this cytokine has been shown to be an important costimulatory growth factor for hematopoietic progenitors.28"0 Our understanding of the biology of FL thus far suggest that this cytokine is active on early hematopoietic progenitors and that it may be part of a redundant network of cytokines that maintains the viability and regulates the growth of stem and progenitor cells. FL differs from KL in that FL does not potentiate erythropoiesis6.' (and work in progress) and apparently does not affect the growth of mature myeloid progenitors. FL does, however, potentiate the growth of human pro-B cells, an activity not shared by KL (R. Namikawa, M.O. Muench, D. Rennick, J.E. de Vries and M.-G. Roncarolo, manuscript submitted). The role of FL in the hematopoietic microenvironment may thus be critical in regulating the balance of the different hematopoietic lineages produced.
